Stock News & Analysis

Microsoft's AI business is booming in multiple aspects.

The cancer test maker could still have a bright future.

As long as AI hyperscalers continue to increase their spending, the chipmaker will thrive.

Everyone hates Broadcom stock today, and Micron is getting caught in the storm.

Investors are getting mixed messages regarding this well-watched company.

Redwire's latest contract probably isn't massive financially, but it highlights its engineering expertise.

This only takes a few minutes, and it's well worth your time.

Movie theaters are having their strongest year since 2019. Patrons are back. Investors should follow.

DexCom posts steady profits and global reach, while Insulet surges ahead with rapid revenue growth and a focused product line. Which strategy stands out?

U.S. stocks were the biggest winners last month, propelled by the tech sector.

Investor enthusiasm soared after an early May announcement and sustained throughout the month.

SEC Chairman Arthur Levitt will resign early next year. In this article, we look back at his career as an advocate for the individual investor and voice the hope that his replacement will continue to give Fools a voice that is heard as clearly as that of Wall Street money managers.

Flying taxis could be coming to a city near you, and Joby Aviation is one company leading the way.

Anthropic makes xAI look significantly overvalued.

Compare diversification strategies and see how each ETF's unique index focus shapes risk and return for healthcare sector investors.

You don't want to end up miserable.

There's a reason Brookfield Renewable Partners has rocketed so much this year.

Snowflake stock surged following its latest quarterly report, but can it sustain that momentum?

This dominant financial services entity has proven to be a winning investment thanks to durable fundamental gains.

This AI-driven data solutions provider reported a notable insider sale as shares trade near multi-year highs following substantial gains.